Preclinical evaluation of a MAGE-A3 vaccination utilizing the oncolytic Maraba virus currently in first-in-human trials
Pol, Jonathan G., Acuna, Sergio A., Yadollahi, Beta, Tang, Nan, Stephenson, Kyle B., Atherton, Matthew J., Hanwell, David, El-Warrak, Alexander, Goldstein, Alyssa, Moloo, Badru, Turner, Patricia V., Lopez, Roberto, LaFrance, Sandra, Evelegh, Carole, Denisova, Galina, Parsons, Robin, Millar, Jamie, Stoll, Gautier, Martin, Chantal G., Pomoransky, Julia, Breitbach, Caroline J., Bramson, Jonathan L., Bell, John C., Wan, Yonghong, Stojdl, David F., Lichty, Brian D., McCart, J. Andrea
Published in Oncoimmunology (01.01.2019)
Published in Oncoimmunology (01.01.2019)
Get full text
Journal Article
Complement Inhibition Prevents Oncolytic Vaccinia Virus Neutralization in Immune Humans and Cynomolgus Macaques
Evgin, Laura, Acuna, Sergio A, Tanese de Souza, Christiano, Marguerie, Monique, Lemay, Chantal G, Ilkow, Carolina S, Findlay, C Scott, Falls, Theresa, Parato, Kelley A, Hanwell, David, Goldstein, Alyssa, Lopez, Roberto, Lafrance, Sandra, Breitbach, Caroline J, Kirn, David, Atkins, Harold, Auer, Rebecca C, Thurman, Joshua M, Stahl, Gregory L, Lambris, John D, Bell, John C, McCart, J Andrea
Published in Molecular therapy (01.06.2015)
Published in Molecular therapy (01.06.2015)
Get full text
Journal Article